ACP
Acuta Capital Partners’s Gyre Therapeutics GYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-365,000
| Closed | -$1.5M | – | 45 |
|
|
2021
Q3 | $1.5M | Sell |
365,000
-320,000
| -47% | -$1.32M | 0.53% | 37 |
|
|
2021
Q2 | $2.97M | Sell |
685,000
-254,500
| -27% | -$1.1M | 1.19% | 28 |
|
|
2021
Q1 | $4.74M | Sell |
939,500
-418,000
| -31% | -$2.11M | 1.71% | 27 |
|
|
2020
Q4 | $8.57M | Sell |
1,357,500
-140,400
| -9% | -$886K | 2.33% | 17 |
|
|
2020
Q3 | $6.44M | Hold |
1,497,900
| – | – | 1.75% | 21 |
|
|
2020
Q2 | $8.79M | Buy |
1,497,900
+113,300
| +8% | +$665K | 2.54% | 13 |
|
|
2020
Q1 | $6.05M | Buy |
+1,384,600
| New | +$6.05M | 2.93% | 13 |
|
|
2018
Q3 | – | Sell |
-830,000
| Closed | -$9.69M | – | 30 |
|
|
2018
Q2 | $9.69M | Sell |
830,000
-324,722
| -28% | -$3.79M | 1.72% | 15 |
|
|
2018
Q1 | $29.8M | Buy |
1,154,722
+704,722
| +157% | +$18.2M | 4.87% | 6 |
|
|
2017
Q4 | $6.14M | Buy |
+450,000
| New | +$6.14M | 1.16% | 14 |
|